Artificial intelligence and its subsets, such as generative artificial intelligence, have been making headlines due to their potential to accelerate the growth and expansion of various industries, including healthcare. However, the majority of application areas in healthcare revolve around diagnosing diseases, finding lead molecules for potential treatments, optimizing hospital operations, and other related aspects. This means that there are areas where the potential of these technologies is still to be realized. Examples of where such technologies could produce a significant impact across multiple elements are clinical research and its related domains, including regulatory submissions, clinical data management, clinical documentation, and other closely related areas. When artificial intelligence and its related technologies are utilized in these areas, they yield unparalleled outcomes regarding efficiency, consistency, and reproducibility. This, in turn, supports professionals involved in clinical research, like medical writers, statistical programmers, and other stakeholders, to drastically improve the speed by which they produce the initial drafts of various outputs, reduce the risk of errors that could lead to submission rejection, and optimize the overall clinical research workflow. Despite the potential of this area, the number of available solutions that support the aforementioned domains remains low. This is further complicated by the fact that there are even fewer numbers of working solutions.
{"title":"Generative AI in Clinical Research: Regulatory Submissions, Clinical Data Management, and Beyond","authors":"Ihab Mansoor, Javier García Ortiz, Matthew Rector","doi":"10.55752/amwa.2024.304","DOIUrl":"https://doi.org/10.55752/amwa.2024.304","url":null,"abstract":"Artificial intelligence and its subsets, such as generative artificial intelligence, have been making headlines due to their potential to accelerate the growth and expansion of various industries, including healthcare. However, the majority of application areas in healthcare revolve around diagnosing diseases, finding lead molecules for potential treatments, optimizing hospital operations, and other related aspects. This means that there are areas where the potential of these technologies is still to be realized. Examples of where such technologies could produce a significant impact across multiple elements are clinical research and its related domains, including regulatory submissions, clinical data management, clinical documentation, and other closely related areas. When artificial intelligence and its related technologies are utilized in these areas, they yield unparalleled outcomes regarding efficiency, consistency, and reproducibility. This, in turn, supports professionals involved in clinical research, like medical writers, statistical programmers, and other stakeholders, to drastically improve the speed by which they produce the initial drafts of various outputs, reduce the risk of errors that could lead to submission rejection, and optimize the overall clinical research workflow. Despite the potential of this area, the number of available solutions that support the aforementioned domains remains low. This is further complicated by the fact that there are even fewer numbers of working solutions.","PeriodicalId":503877,"journal":{"name":"AMWA Journal","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140241398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The John P. McGovern Award is named in honor of John P. McGovern and is presented to a member or nonmember of AMWA to recognize a preeminent contribution to any of the various modes of medical communication. The McGovern Award is presented during AMWA’s Medical Writing & Communication Conference.
John P. McGovern奖是为了纪念John P. McGovern而命名的，颁发给AMWA的会员或非会员，以表彰他们在各种医学传播方式中做出的杰出贡献。麦戈文奖在 AMWA 的医学写作与传播大会期间颁发。
{"title":"2023 John P. McGovern Award Address","authors":"Jessica Steier, Andrea Love","doi":"10.55752/amwa.2024.329","DOIUrl":"https://doi.org/10.55752/amwa.2024.329","url":null,"abstract":"The John P. McGovern Award is named in honor of John P. McGovern and is presented to a member or nonmember of AMWA to recognize a preeminent contribution to any of the various modes of medical communication. The McGovern Award is presented during AMWA’s Medical Writing & Communication Conference.","PeriodicalId":503877,"journal":{"name":"AMWA Journal","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140243692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The human gut microbiome, comprising a range of microbial species (~100 to 1,000), is an extremely malleable ecosystem. It originates around the time of human birth and evolves as the infant grows until it matures into the relatively stable adult gut composition. Through this dynamic evolution, the composition of the gut microbiome is influenced or altered by factors such as diet, environment, mode of birth, genetics, infections, and medications. Strong associations between such alterations (dysbiosis) and diseases have led scientists to develop therapies that target a malfunctioning gut. Research is now focused on the microbiota or their associated metabolites as potential therapies. Treatment options explored include prebiotics, probiotics, postbiotics, synbiotics, fecal microbiota transplants, and live biotherapeutic products. The gut microbiome is not a panacea for all health issues; rather, it is part of a large network of interconnected operating systems within the human body. As communicators of scientific data, medical writers play a vital role in educating the public on the merits and limitations of gut microbiome therapeutics. Popular discourse, however, can be influenced by misinformation. With the ever-growing influence of social media, the lay reader must learn how to critically appraise the health information propagated by these sources. This second part of the gut microbiome series explores the association of the gut microbiome with human disease and the role that social media plays in influencing the popular perception and understanding of the importance of the gut microbiome. Approved and experimental therapies using the gut microbiome will be discussed.
{"title":"The Gut Microbiome–Human Body Symbiosis: Relevance of the Ubiquitous Microbial Community on Health and Development, Part 2","authors":"Smitha Dutt","doi":"10.55752/amwa.2024.308","DOIUrl":"https://doi.org/10.55752/amwa.2024.308","url":null,"abstract":"The human gut microbiome, comprising a range of microbial species (~100 to 1,000), is an extremely malleable ecosystem. It originates around the time of human birth and evolves as the infant grows until it matures into the relatively stable adult gut composition. Through this dynamic evolution, the composition of the gut microbiome is influenced or altered by factors such as diet, environment, mode of birth, genetics, infections, and medications. Strong associations between such alterations (dysbiosis) and diseases have led scientists to develop therapies that target a malfunctioning gut. Research is now focused on the microbiota or their associated metabolites as potential therapies. Treatment options explored include prebiotics, probiotics, postbiotics, synbiotics, fecal microbiota transplants, and live biotherapeutic products. The gut microbiome is not a panacea for all health issues; rather, it is part of a large network of interconnected operating systems within the human body. As communicators of scientific data, medical writers play a vital role in educating the public on the merits and limitations of gut microbiome therapeutics. Popular discourse, however, can be influenced by misinformation. With the ever-growing influence of social media, the lay reader must learn how to critically appraise the health information propagated by these sources. This second part of the gut microbiome series explores the association of the gut microbiome with human disease and the role that social media plays in influencing the popular perception and understanding of the importance of the gut microbiome. Approved and experimental therapies using the gut microbiome will be discussed.","PeriodicalId":503877,"journal":{"name":"AMWA Journal","volume":"19 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140244262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：